First biomarker discovered that predicts prostate cancer outcome

Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery. The report on the B7-H3 molecule by Mayo Clinic Cancer Center appears today in Cancer Research.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news106371414.html">First biomarker discovered that predicts prostate cancer outcome</a></p> <p>Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery. The report on the B7-H3 molecule by Mayo Clinic Cancer Center appears today in <i>Cancer Research</i>.</p>